The QualityStocks Daily Thursday, January 17th, 2019

Today's Top 3 StockMarketWatch

Penny Stock Titans (BTOP) +71.48%

StockMarketWatch (LMFA) +49.30%

NetworkNewsWire (SSOF) +27.92%

The QualityStocks Daily Stock List

Golden Arrow Resources Corp. (GARWF)

Money and Markets and FutureMoneyTrends reported earlier on Golden Arrow Resources Corp. (GARWF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Golden Arrow Resources Corp. is an explorer and prospect generator. The Company’s focus is on identifying, acquiring, and advancing precious and base metal discoveries with the objective of defining first-class deposits. Its main emphasis is on advancing its flagship Chinchillas Silver Project in Jujuy Province, Argentina. Golden Arrow Resources is a member of the Grosso Group; a management company specializing in resource exploration. Golden Arrow Resources has exploration offices in Ciudad de Mendoza, Argentina.

The Company’s other Argentina projects include the Antofalla Silver-Gold-Base Metal Project in Catamarca Province; and the Don Bosco Copper-Gold Project and the Caballos Copper-Gold Project, both in La Rioja Province.

Additionally, projects include the Mogote Copper-Gold Project; the Pescado Gold Project; and the Frontera District - Potrerillos Gold-Silver Project. All of these projects are in San Juan Province.

The Chinchillas Silver deposit will be developed into a satellite open-pit mine. The Chinchillas Silver Project features low capex (capital expenditure) and fast-tracked development utilizing infrastructure from the Pirquitas mine. It has a positive pre-feasibility study with strong economics and immediate production income from the Pirquitas mine operation.

Golden Arrow Resources formed a Joint Venture (JV) with Silver Standard Resources, Inc. announced on May 31, 2017. This JV is called Puna Operations, Inc. (POI). It was created to hold the Chinchillas project and the Pirquitas project, which consists of the San Miguel open pit mine that ended mining operations in January 2017 (the Pirquitas Pit), and the associated mineral processing facilities and tailings facility (the Pirquitas Operation) in Argentina. POI is 75 percent owned and operated by Silver Standard, and owned 25 percent by Golden Arrow Resources.

Puna Operations has received approval of the Environmental Impact Assessment (EIA) that allows for the exploitation of the Chinchillas silver lead zinc deposit in Jujuy Province, Argentina. This paves the way for expected delivery of first ore from Chinchillas to the Pirquitas mill in the second half of this year, eventually reaching planned life of mine annual average production of 8.4M ounces silver equivalent.

Golden Arrow Resources has also formed a 100 percent owned subsidiary named “New Golden Explorations, Inc.” This subsidiary will seek a listing on the stock exchange to access funding for future exploration. Golden Arrow’s intention is to initially give up 40 percent and retain a 60 percent carried interest on new discovery values.

At present, New Golden Explorations is exploring. It plans on drilling three very advanced prospects to realize new discoveries. Exploration restarted on all the projects on January 7, 2018. This created a second value stream for shareholders of Golden Arrow.

Recently, Golden Arrow Resources announced that it started the first diamond drill program at the Antofalla silver-gold-base metal project in Catamarca Province, Argentina. The program is planned to include up to 3,000 meters of drilling on numerous targets, which were delineated in the 2017 surface exploration and trenching programs.

Golden Arrow Resources Corp. (GARWF), closed Thursday's trading session at $0.2279, up 1.15%, on 19,828 volume with 19 trades. The average volume for the last 3 months is 93,067 and the stock's 52-week low/high is $0.169/$0.574.

chart

Tempus Applied Solutions Holdings, Inc. (TMPS)

MarketWatch and InvestorsHub reported on Tempus Applied Solutions Holdings, Inc. (TMPS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Tempus Applied Solutions Holdings, Inc. provides design, engineering, systems integration, and flight operations solutions. These support critical aviation mission requirements for a variety of customers. The OTCQB-listed Company maintains a highly qualified and skilled in-house engineering team, which supports aircraft modifications, certification, maintenance, and flight testing.

Tempus Applied Solutions, LLC is the wholly-owned subsidiary of Tempus Applied Solutions Holdings; Inc. Tempus Applied Solutions has its corporate office in Williamsburg, Virginia. The Company uses a secure facility with hangar and manufacturing space and secure communications at Brunswick Executive Airport. The facility has two parallel 8000’ x 200’ runways and a 4.5-million-square-foot ramp and taxiways - certified for B-747, A-340, and and C-5 aircraft.

Tempus has in-house DER (Designated Engineering Representatives) capabilities covering 41 categories of aircraft systems. Capabilities include Part 23 Aircraft and Part 25 Aircraft and also Repair Station DER. In addition, authorities encompass mechanical systems, electrical systems, and flight testing.

The Tempus Design & Engineering Center of Excellence has Designated Engineering Representative (DER) authority from the Federal Aviation Administration (FAA) and the European Aviation Safety Agency (EASA). This center’s specialties include major airframe modifications; interior completions projects; design and materials specifications; modeling and rendering utilizing 3D Max Vision; Supplemental Type Certificates (STC); and Layout of Passenger Accommodations (LOPA) Development.

Tempus flies airplanes - fixed wing and rotary, manned or unmanned. The Company engages in surveillance missions in Africa to flight training in Texas. Also, Tempus designs and modifies aircraft for special missions, certifies them, and provides turnkey lease and service solutions.

Tempus operates Gulfstream, Bombardier, Pilatus, and Cessna aircraft. The majority of these aircraft have been specially modified by the Company for Department of Defense (DoD)-related missions. This includes threat simulation, surveillance, communications relay, and diverse test and development programs.

The Tempus Applied Solutions subsidiary was awarded FAA (Federal Aviation Administration) approval, in the form of a Supplemental Type Certificate (STC), for Tempus' initial FANS/1-A and ADS-B compliance solution [(Tempus' "Solution AA")]. Tempus' solution received an "Approved Model List", or AML, STC. This means that it can be applied to any business and commercial aircraft. FANS and ADS-B compliance will be mandated in most parts of the world by 2020.

Recently, Tempus Applied Solutions announced that it finalized the acquisition of six Lockheed L-1011s previously owned and operated by the Royal Air Force (RAF) of the United Kingdom.  Four of these aircraft are specifically configured for air-to-air refueling (AAR) operations. The remaining two are configured for passenger and cargo operations only. The aircraft beforehand served the RAF and NATO.

Tempus Applied Solutions Holdings, Inc. (TMPS), closed Thursday's trading session at $0.1445, up 0.35%, on 3,500 volume with 3 trades. The average volume for the last 3 months is 7,511 and the stock's 52-week low/high is $0.031/$0.38.

chart

Avita Medical Limited (AVMXY)

Zacks, Amigo Bulls, Speculating Stocks, Marketbeat, OTC Markets, The Street, The StreetWise Reports, TradingView, InvestorsHub, MarketWatch, Stockhouse, StockInvest.us, StreetInsider, Marketwired, Penny Stock Picks, HotCopper, Business Insider, GuruFocus, WalletInvestor, 4-Traders, and Edison Investment Research reported on Avita Medical Limited (AVMXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A medical device company, Avita Medical Limited provides an innovative approach to skin regeneration. The Company’s products are for the treatment of a broad spectrum of wounds, scars, as well as skin defects. These products are presently available directly in the United Kingdom (UK), Germany, Australia and New Zealand and around the world through distributors in France, Belgium, Netherlands, Turkey, China, Malaysia, Taiwan, Iran and South Africa.

Avita Medical operates from offices in Wimbledon, UK; Valencia, California, and Perth, Australia. The Company lists on the OTCQX.

In all countries outside of Europe, Avita Medical’s portfolio is marketed under the ReCell® brand to promote skin healing in a broad array of applications. This includes burns, chronic wounds, as well as aesthetics. In the U.S., ReCell® is an investigational device limited by federal law to investigational and compassionate use.

Avita Medical’s patented and proprietary collection and application technology provides unique treatment solutions derived from the regenerative properties of a patient’s own skin. The Company’s medical devices work by preparing a Regenerative Epithelial Suspension (RES™). This is an autologous suspension consisting of the patients’ own skin cells and wound healing factors, which are essential to regenerate natural healthy skin. This is subsequently applied to the area to be treated.

In Europe, Avita Medical’s portfolio of medical device products received CE-mark approval as three tailored product presentations, with three individual brand names. These are ReCell®, ReGenerCell™, and ReNovaCell™.

The design of ReCell® is for the treatment of burns and plastic reconstructive procedures. ReGenerCell™ has been formulated for chronic wounds. This includes leg and foot ulcers. ReNovaCell™ is tailored for aesthetic applications. This includes the restoration of pigmentation.

This past April, Avita Medical announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness (third-degree) burns with the RECELL® Autologous Cell Harvesting Device realized its co-primary endpoints, demonstrating a statistically significant reduction in donor skin requirements in comparison to standard of care while attaining comparable definitive wound closure. The results were presented at the American Burn Association (ABA) 50th Annual Meeting in Chicago, Illinois by James H. Holmes, IV, MD, FACS, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.

Last month, Avita Medical announced that results from a study validating the predicted outcomes and costs from an acute burns health economic model were presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Maryland.

The milestone model is the first validated economic model available to assess the costs and clinical impact of new interventions in comparison to standard of care for inpatient treatment of acute burns along the burn care continuum. The model demonstrates the ability to predict the cost-effectiveness, incremental costs and the budget impact of diverse care management approaches.

Recently, Avita Medical announced an institutional placement of A$16.0 million to prepare for the planned U.S. launch of the RECELL® Device in the treatment of severe burns. The Company received commitments from global and Australian institutional and sophisticated investors for a placement of A$16.0 million at an issue price of A$0.050 per share, with the placement to take place in two tranches.

Avita Medical Limited (AVMXY), closed Thursday's trading session at $1.73, up 1.67%, on 124,537 volume with 76 trades. The average volume for the last 3 months is 97,688 and the stock's 52-week low/high is $0.77/$2.15.

chart

Blue Sphere Corp. (BLSP)

Fast Money Alerts, PennyStocks24, MyBestStockAlerts, OTPicks, Penny Stock General, Stock Shock and Awe, PremiereStockAlerts, DreamTeamNetwork, and SmallCapVoice reported previously on Blue Sphere Corp. (BLSP), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Blue Sphere Corp. is an international Independent Power Producer (IPP). The Company is working to become a key player in the global waste-to-energy and renewable energy markets. It has a business plan that fits the changing regulatory standards for waste and energy. Blue Sphere develops, owns, and operates clean-tech, biogas cogeneration and waste-to-energy facilities around the world. It mainly converts organic waste into electricity. In addition, the Company has the ability to generate heat, natural gas and organic by-products via a variety of technologies.

A clean-technology waste-to-energy producer, Blue Sphere’s principal business model is BOO (Build-Own-Operate) - long-term energy agreements are executed with electric companies in advance of projects. Blue Sphere has its headquarters in Charlotte, North Carolina. A waste-to-energy project integrator, the Company has operations in the U.S., Israel, and Europe.

Blue Sphere is performing waste-to-energy projects in the U.S. and Italy. It is pursuing a strategy to work in association with landfill owners to convert harmful methane gas emissions from landfills into electricity. The process is established on readily available technology already being used in different parts of the U.S. and other areas around the world.

Blue Sphere has its Charlotte, North Carolina Waste to Energy Anaerobic Digester 5.2 MW Plant. In Johnston, Rhode Island, the Company has its Waste to Energy Anaerobic Digester 3.2 MW Plant.

Blue Sphere has acquired 100 percent of the stock of Agricerere, S.R.L., Agrielektra, S.r.L., Agrisorse, S.r.L. and Gefa, S.r.L. Individually, each fully operational facility produces one megawatt of electricity per hour that sells to Gestore del Servizi Energetici GSE, S.p.A., which is a state owned company, which promotes and supports renewable energy sources in Italy, under a Power Purchase Agreement (PPA) that runs through December 31, 2027.

Blue Sphere Corp. (BLSP), closed Thursday's trading session at $0.0004, up 14.29%, on 123,304,061 volume with 78 trades. The average volume for the last 3 months is 65,596,391 and the stock's 52-week low/high is $0.0003/$2.00.

chart

Fiore Gold Ltd. (FIOGF)

Stock Orange, Investors Hangout, Barchart, Stockhouse, Energy and Gold, Stockwatch, and WatchDog Stocks reported on Fiore Gold Ltd. (FIOGF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Fiore Gold Ltd. is a new America’s-focused gold producer and explorer. The Company has the producing Pan Mine in the State of Nevada. Moreover, it has a group of exploration projects in Nevada, Washington and Chile. Fiore Gold’s objective is to build a new mid-tier mining company in the world’s top mining jurisdictions. The Company’s initial goal is on becoming a 150,000-ounce/year gold producer. Fiore Gold has offices in Toronto, Ontario; Vancouver, British Columbia; and Englewood, Colorado.

Concerning South American Properties, Fiore Gold has its Pampas El Peñon properties; the Cerro Tostado project; and the Rio Loa property. The Pampas El Peñon property comprises 13 mining claims totaling 3,400 hectares. It is located about 130 kilometers southeast of Antofagasta, Chile.

Regarding North American Projects, the Company’s assets include the above-mentioned, producing Pan Mine near Eureka, Nevada. Assets also include the nearby Gold Rock exploration project. Also, the Company controls the Golden Eagle advanced exploration project in Washington State.

The Pan Mine is a Carlin-style, sediment-hosted, gold-only deposit. It consists of three main zones of mineralization that has currently been traced for greater than 6,000 feet along the north-south Branham Fault. The 2017 Pan Mine Feasibility Study (FS) defines Proven and Probable reserves of 318,000 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton).

The Cerro Tostado (South America) project consists of five concessions totaling around 1,500 ha situated in Region II approximately 125 km southeast of Antofagasta. Cerro Tostado is positioned just south of the main and Fortuna zones of Yamana Gold's flagship El Peñon Mine.

The Rio Loa property is situated in the northern part of the prolific Maricunga gold belt. The 1,000 Ha Rio Loa property is located approximately 25 km south of Salares Norte. This property is accessible year-round by road.

In November 2017, Fiore Gold announced the results of the Phase I diamond and reverse-circulation (RC) drilling program at its Cerro Tostado project in Chile, following up on high-grade epithermal silver mineralization earlier intersected by three of 18 holes drilled between 2010 and 2012 by Sociedad Quimica Y Minera de Chile SA (SQM).

Phase 1 of the Cerro Tostado program included four oriented-core diamond drill holes targeting the earlier-identified high-grade silver mineralization. In addition, the program included two new targets identified from mapping, surface sampling, and trenching.

Recently, Fiore Gold announced the start of exploration drilling at its Pan Mine in Nevada, as part of a longer-term program intended to expand the resource and reserve base at Pan. This present program will consist of roughly 11,500 feet of reverse circulation drilling and be centered in the vicinity of the North Pit that hosts most of the silica-rich rocky ore at Pan.

Moreover, drilling will take place in the Central area of the deposit to expand existing resources there and test new targets. Mining is now taking place in the rocky North Pan Zone and the clayey South Pan Zone, with the run-of-mine ores blended on the leach pad.

Fiore Gold provided results from the first six holes of its 2018 drill program at its Pan Mine in Nevada. Highlights from the first six holes include Hole PND18-06 returning 79.2 meters of 0.55 g/t (260 ft of 0.016 oz/t gold); Hole PND18-03 intercepted 82.3 m of 0.45 g/t gold (270 ft of 0.013 oz/t gold); and Hole PND18-01 drilled 65.5 m of 0.38 g/t gold (215 ft of 0.011 oz/t).

Fiore Gold Ltd. (FIOGF), closed Thursday's trading session at $0.299, up 12.41%, on 49,115 volume with 12 trades. The average volume for the last 3 months is 72,476 and the stock's 52-week low/high is $0.157/$0.732.

chart

MGX Minerals, Inc. (MGXMF)

InvestorsHub, Stockhouse, Capital Equity Review, The Street, Stockwatch, The StreetWise Reports, MarketWatch, OTC Markets, Morningstar, 4-Traders, and Barchart reported on MGX Minerals, Inc. (MGXMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MGX Minerals, Inc. is a diversified resource company based in Vancouver, British Columbia. The Company centers on the development of large-scale industrial mineral portfolios in specific commodities and jurisdictions that will fuel the new energy economy. MGX Minerals controls significant interest in lithium, magnesium and silicon assets throughout North America. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Regarding size and scale, MGX Minerals has regional control in the majority of industrial mineral projects in the jurisdictions it operates. Moreover, concerning near-term potential, MGX concentrates on assets that offer streamlined development timelines and low initial capital expenditures (Capex).

MGX Minerals’ business strategy is to identify commodities as well as jurisdictions where large-scale development opportunities exist. Its strategy is to also build its asset portfolio through aggressive acquisition to quickly build and enhance long-term portfolio value. Furthermore, its strategy is to engage industry experts to lessen execution risk and speedily increase time to market.

The Company has developed a proprietary, low-energy design process (Rapid Recovery Process) that is patent-pending. The design of it is specifically for highly-mineralized brine associated with oilfields. The process quickly concentrates lithium and other minerals in brine.

Regarding independent confirmation of the Rapid Recovery Process, testing was carried out by a third-party laboratory (Saskatchewan Research Council (SRC)). SRC successfully recovered 83.7 percent of lithium from a representative sample of brine. Lithium was concentrated to 461 ppm from the representative sample containing 71 ppm.

MGX Minerals announced that its 100 percent wholly-owned subsidiary ZincNyx Energy Solutions entered into a Partnership Agreement with Digital Energy Corporation to deploy Zinc-Air Fuel Cell Technology in New York City. With this agreement, Digital Energy will install the ZincNyx battery system at a demonstration site in New York City.

Upon successful completion of the initial project, ZincNyx and Digital Energy will develop more installation sites. They will also work to expand distribution of the ZincNyx technology. Digital Energy is a project development and energy consulting firm.

ZincNyx works to meet the increasing need for secure and reliable power. MGX Minerals’ intention is to publicly list ZincNyx and pay a partial share dividend to MGX shareholders of record.

Last week, MGX Minerals provided an update on its Paradox Basin Petrolithium Project. The Project includes the 80,380-acre Blueberry Unit, a recently unitized Federal Oil and Gas Unit created as part of the Project. The 110,000 acre Paradox Project represents the first large-scale integrated petroleum and lithium exploration project in the U.S. It is situated proximate to the Lisbon Valley oilfield within the Paradox Basin.

After approximately two months of fieldwork, crews have completed Paleontology Surveying. They are nearing completion of the Archeological Survey. So far, all locations have been surveyed out with 163 new sites located along with 12 sites that need re-documenting.

Documentation recording for the survey started last week and will take about one week to complete. Pending Bureau of Land Management (BLM) approval, a Seismic Survey at the Paradox Project is scheduled to begin in early August.

In North America, MGX Minerals reports the completion of brine analysis and pilot plant processing of samples originating from an industrial wastewater stream and geothermal lithium brine samples. Its investment bank Capstone Headwaters LLC is assisting in negotiations.

In South America, MGX Minerals has completed pilot plant testing on brine samples originating from manifold salars situated in Chile. The Company has entered into a joint brine testing agreement with several South American mining companies. The parties are now working to identify potential joint-venture (JV) locations, which will utilize MGX’s lithium extraction technology.

MGX Minerals, Inc. (MGXMF), closed Thursday's trading session at $0.3345, up 11.09%, on 212,356 volume with 102 trades. The average volume for the last 3 months is 188,072 and the stock's 52-week low/high is $0.224/$1.58.

chart

Patriot One Technologies, Inc. (PTOTF)

OTC Markets, Zacks, Barchart, Stockhouse, and InvestorsHub reported on Patriot One Technologies, Inc. (PTOTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Patriot One Technologies, Inc. develops radar device and software solutions.  The Company and a research team at McMaster University in Hamilton, Ontario have come together to commercialize a system to detect concealed weapons utilizing novel radar technologies and custom software solutions. A technology enterprise, Patriot One Technologies is based in Burlington, Ontario.

The Company has developed PATSCAN™. This is the next generation of its award-winning Patriot One Technologies™ NForce CMR1000 software and radar solution. PATSCAN™ is a first-of-its-kind Cognitive Microwave Radar (CMR) concealed weapons detection system as an effective tool to combat active shooter threats before they occur.

Patriot One Technologies is commercializing its PATSCAN™ CMR technology as an automated alert system capable of covertly screening moving individuals for on-body concealed weapons. It can alert security of an active threat entering the site.

PATSCAN has completed all requisite testing. It now has certification by the European Telecommunications Standards Institute (ETSI). This makes PATSCAN saleable in 66 countries across Europe, the Middle East, and Asia.

The design of the Patriot One software solution and related hardware is for cost-effective deployment in weapon-restricted buildings and facilities. It can be installed in hallways and doorways.

PATSCAN identifies threats by database comparison of known weapons profiles, and via detection of concealed irregular object mass. The Company’s patented Cognitive Microwave Radar (CMR) uses a network-wide ability to “learn” and adapt to new threats as “signature” patterns are identified. Pattern updates are transmitted network-wide. This provides an ever increasing signature library.

Active PATSCAN CMR technology testing has continued to advance utilizing a staged approach: Stage 1 included years of academic research. Stage 2 combined advances in software development, radar performance studies and equipment form factor enhancements concluding with equipment certifications and advancement to Stage 3.

The Company’s deployment of the PATSCAN CMR solution during Q1/Q2 2018 is targeting many U.S. and Canadian municipal, educational, and governmental sites. The aim is to expedite systems deployment in Florida, the U.S. Midwest, and Canada. This is to advance Patriot One’s machine learning processes across numerous live interactive customer locations.

In late March, Patriot One Technologies provided a corporate update. The Company spent the month of March updating its development center rollout with U.S., Canadian, and U.K reseller partners.

Furthermore, outreach to U.S. Congressional leaders facilitated introductions and information sharing regarding Patriot One and its PATSCAN CMR solution. The Company noted that the information sessions were favorably met and will help ensure that present and future safe-school legislation remains open to all forms of detection technologies.

Patriot One Technologies won the 2017 Anti-Terrorism/Force Protection category of the Security Industry Association's New Product Showcase at ISC West.

Patriot One Technologies, Inc. (PTOTF), closed Thursday's trading session at $1.51, up 5.60%, on 116,874 volume with 150 trades. The average volume for the last 3 months is 265,550 and the stock's 52-week low/high is $0.926/$2.29.

chart

Semler Scientific, Inc. (SMLR)

Money Morning, Wall Street Resources, Marketbeat.com, and Barchart reported previously on Semler Scientific, Inc. (SMLR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Semler Scientific, Inc. is a medical risk-assessment Company listed on the OTC Markets’ OTCQB. Its mission is to develop, manufacture, and market patented products, which identify the risk profile of medical patients to permit healthcare providers to capture full reimbursement potential for their services. Semler Scientific provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups. Semler Scientific is based in Portland, Oregon.

The Company’s diagnostic and testing products and services assist in guiding patient care. They close the gap between the cost of care and compensation for care.

Fundamentally, Semler Scientific provides diagnostic and testing services to the U.S.’s top health plans and providers. The Company’s aim is to develop, manufacture, and market unique proprietary products and services that assist its customers in evaluating and treating chronic diseases.

Semler Scientific manufactures the QuantaFlo™ system for Vascular Disease testing. The QuantaFlo™ system is very suitable for use in primary care offices, specialty practices, health fairs, or during home assessments.

The QuantaFlo™ PAD test delivers fast, accurate results in about five minutes at the point of care. In March of 2015, Semler Scientific received Food and Drug Administration (FDA) 510 (k) clearance for the next generation version of QuantaFlo™, which commercially launched in August of 2015.

The Company also has its WellChec™ service. WellChec™ provides turn-key assessment testing across the U.S. for an assortment of conditions. It provides turnkey solutions for administering important clinical tests, which can impact HCC classifications, CPT coding, HEDIS and Quality Measures. The Company launched its multi-test service platform, WellChec™ in April of 2015.

In October of 2016, Semler Scientific shifted its marketing emphasis for WellChec™ from direct contracts with health insurance plans under which the Company acted as the primary WellChec™ service provider to contracts to supply its software and equipment to vendors who employ medical professionals to do yearly wellness visits for health insurance plans.

Semler Scientific, Inc. (SMLR), closed Thursday's trading session at $37.85, up 2.99%, on 5,432 volume with 38 trades. The average volume for the last 3 months is 23,419 and the stock's 52-week low/high is $6.45/$40.00.

chart

Amarantus Bioscience Holdings, Inc. (AMBS)

Streetwise Reports, InvestorsHub, Stockopedia, Nasdaq.com, Stockhouse, 4-Traders, Zacks and Insider Financial reported on Amarantus Bioscience Holdings, Inc. (AMBS), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Amarantus Bioscience Holdings, Inc. is JLABS-alumnus biotechnology holding company. It is developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies by way of its subsidiaries. The Company’s wholly-owned subsidiaries include Elto Pharma, Inc; Cutanogen Corporation, and MANF Therapeutics.

In addition, Amarantus Bioscience Holdings owns roughly 79.25 million shares of Avant Diagnostics, Inc. (AVDX) through the sale of its wholly-owned subsidiary Amarantus Diagnostics, Inc. which took place in May of 2016. Established in 2008, Amarantus Bioscience Holdings has its headquarters in New York, New York.

The Company is concentrating on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. Its lead therapeutic program is eltoprazine. This is a Phase 2b-ready small molecule indicated for the treatment of Levodopa-induced dyskinesia, which is one of the most difficult problems facing patients with Parkinson’s disease.

Eltoprazine is also undergoing evaluation for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer’s aggression. Elto Pharma has development rights to eltoprazine.

The Company’s diagnostics division is Amarantus Diagnostics. Its lead diagnostic product is LymPro Test®. This is a blood based assay to diagnose Alzheimer’s disease. LymPro Test® is approved for investigational use only to be used in biotechnology and pharmaceutical clinical trials.

Additionally, Amarantus Diagnostics is developing MSPrecise®. This is a proprietary, next-generation DNA sequencing (NGS) assay for the identification of patients with relapsing-remitting multiple sclerosis (RRMS) at first clinical presentation.

Furthermore, Amarantus Bioscience Holdings acquired the rights to the Engineered Skin Substitute program. This is a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture, which is being pursued by subsidiary Cutanogen Corporation.

Amarantus’ subsidiary MANF Therapeutics owns key intellectual property (IP) rights and licenses from several prominent universities related to the development of the therapeutic protein called mesencephalic astrocyte-derived neurotrophic factor (MANF). MANF Therapeutics is developing MANF-based products as treatments for brain and ophthalmic disorders.

MANF was discovered by Amarantus Bioscience’s Chief Scientific Officer John Commissiong, PhD.  Dr. Commissiong discovered MANF from Amarantus' proprietary discovery engine PhenoGuard.

Recently, Company subsidiary Elto Pharma announced that it received a notice of allowance from the Australian Patent Office for a patent application entitled "Treatment of Motor and Movement Disorder Side Effects Associated With Parkinson's Disease Treatments" that protects use of Eltoprazine for the treatment of PD-LID. This includes the use of Eltoprazine in combination with other relevant Parkinson's therapeutics.

Upon issuance, the allowed patent will extend exclusivity for the use of Eltoprazine in Australia for the treatment of PD-LID into 2032. Eltoprazine received orphan drug designation from the US FDA (Food and Drug Administration) for PD-LID in February of 2016.

Amarantus Bioscience Holdings, Inc. (AMBS), closed Thursday's trading session at $0.04368, up 2.18%, on 1,495,539 volume with 81 trades. The average volume for the last 3 months is 456,520 and the stock's 52-week low/high is $0.0151/$0.1175.

chart

Adama Technologies Corporation (ADAC)

StreetInsider, InvestorsHub, OTC Markets, Morningstar, and Stockhouse reported on Adama Technologies Corporation (ADAC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Adama Technologies Corporation is a Venture Capital Company listed on the OTCQB. It owns, operates, and invests in technology companies and also startups and expansion companies. The Company has a hands-on approach and works to develop the management and leaders around the corporate landscape to transform big ideas into game changing execution in the field. Adama Technologies has its corporate office in Henderson, Nevada.

Adama Technologies has exceptional access to equity lines of credit, equity funds, private investors, incubators, mentor partners and close ties with Fortune 100, 500 and 1000 companies who serve as exit strategies for many of Adama’s investments.

Adama Technologies’ portfolio companies include Alpine Industries and SafeGuard Pii. Its flagship investment is Alpine Industries located in Utah. Alpine specializes in machining and aerospace manufacturing.

This investment and acquisition launches Adama Technologies into the fast expanding field of aerospace technology. Furthermore, it positions Adama with the stability of being a defense contractor for the U.S. military.

Since its establishment in 1974, Alpine Industries has manufactured several hundred aerospace landing gear components and other spare parts.  It continues to work as a US government contractor.

Presently, Alpine holds more than 15 US Military contracts. Most of these contracts are with the US Air Force. Alpine Industries also manufactures parts for a number of private companies. These include parts for drilling components utilized in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, as well as drilling carts.

SafeGuard Pii is an industry pioneer and top-tier Privacy Management Firm. It provides compliance solutions to companies across the United States.  In addition, SafeGuard Pii is the provider of a strong identity theft protection and restoration product.

The Company’s PII Defender program monitors internet black market sites, other internet trading sites where ID thieves buy and sell information, utility and phone records, public databases, criminal databases and DMV records, plus credit files for one’s personal information.

Adama Technologies Corporation (ADAC), closed Thursday's trading session at $0.0025, up 25.00%, on 262,720 volume with 11 trades. The average volume for the last 3 months is 279,492 and the stock's 52-week low/high is $0.009/$0.18.

chart

OceanaGold Corporation (OCANF)

Stockhouse, TipRanks, InvestorsHub, Stockwatch, Dividend Investor, WalletInvestor, OTC Markets, TradingView, SimVest, Stockscores, SmallCap Network, and Insider Monkey reported on OceanaGold Corporation (OCANF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OceanaGold Corporation is a mid-tier, high-margin, multinational gold producer. The Company has assets in the U.S., the Philippines, and New Zealand. Its flagship asset is the Didipio gold-copper mine situated on the island of Luzon in the Philippines. In 2018, the Didipio underground is progressing to plan. OceanaGold has its corporate office in Melbourne, Australia. The Company’s Americas corporate office is in Vancouver, British Columbia.

On the North Island of New Zealand, OceanaGold operates the high-grade Waihi Gold Mine. The Company has started permitting of a 10-year mine life extension at Waihi.

On the South Island of New Zealand, it operates the largest gold mine in the nation at the Macraes Goldfield that consists of a series of open pit mines and the Frasers underground mine.

In the U.S., OceanaGold operates the Haile Gold Mine. This is a top-tier, long-life, high-margin asset located in South Carolina. In 2016, OceanaGold completed the construction of the Haile Gold Mine. It achieved commercial production at Haile in 2017. This year, the Haile process plant expansion is underway.

In addition, the Company has a significant pipeline of organic growth and exploration opportunities in the Americas and Asia-Pacific regions. In 2018, OceanaGold is processing high grade ore from Coronation North.

OceanaGold expects to produce 480,000 to 530,000 ounces of gold and 15,000 to 16,000 tonnes of copper in 2018, with All-In Sustaining Costs (AISC) that range from $725 to $775 per ounce sold.

In December of 2017, eight mining companies engaged in mining, processing and distribution of mineral products in the ASEAN region were recognized at the 1st ASEAN Mineral Awards. These companies were recognized for their achievements to support an environmentally and socially sustainable minerals sector. OceanaGold was awarded the winner of Best Practice in Minerals Processing category.

OceanaGold has its Argentina Joint Ventures (JVs). The Company has the potential to earn-in up to 75 percent on each project in this prolific gold region.

An element of OceanaGold’s business strategy is to develop new reserves and resources at its existing mines from in-pit and near mine exploration or from satellite projects positioned within the present tenements. Another element of its business strategy is to maintain steady-state production in New Zealand to maximize profitability via efficient operations and prudent investment.

OceanaGold Corporation (OCANF), closed Thursday's trading session at $3.59, up 1.26%, on 19,790 volume with 33 trades. The average volume for the last 3 months is 53,698 and the stock's 52-week low/high is $2.35/$3.74.

chart

Union Bridge Holdings Limited (UGHL)

StreetInsider, TheHotPennyStocks, CapitalCube, Penny Fix, Barchart, Hot Copper, WalletInvestor, 4-Traders, Morningstar, InvestorsHub, MarketWatch, Stockhouse, YCharts, GuruFocus, OTC Markets, Simply Wall St, TradingView, Business Insider, and OTC Research reported on Union Bridge Holdings Limited (UGHL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 2014, Union Bridge Holdings Limited is engaging in senior-care projects. The Company previously went by the name Costo, Inc. It changed its corporate name to Union Bridge Holdings Limited in June of 2016. Union Bridge Holdings’ shares trade on the OTC Markets Group’s OTCQB. The Company has its head office in Hong Kong.

Last month, Union Bridge Holdings announced that its subsidiary, Windsor Honour Limited (WHL), entered into a Binding Heads of Agreement to enter into a cooperative venture with the owner of a land parcel of roughly 4,250 sq. m. in Chae Chang Sub-district, Sankamphaeng District, Chiang Mai Province, Thailand, for building and operating a senior-care nursing home facility.  The facility is proposed to have four blocks, each with eight floors, and house around 400 residents.

Total investment in the Project for development and construction is estimated to be about 200 million Thai Baht (roughly US$6.4 million at current exchange rates). The Project would lease the land for 90 years with automatic renewal each 30 years.

Mr. Joseph Ho, Union Bridge Holdings’ Chief Executive Officer, said, "We believe it is a very important milestone for the Company to kick off the development of a senior home in Asia, and specifically in Thailand, as we continue to pursue the long-term growth of the Company."

This week, Union Bridge Holdings announced that its subsidiary, Phoenix Creation Global Limited entered into a Letter of Intent (LOI) with Shenyang Shenhe Yixi Home Care Service Center (Shenyang Yixi) to enter into a joint venture (JV) to promote the development of the elderly care business in China. Phoenix Creation Global would own 65 percent and Shenyang Yixi would own 35 percent.

Shenyang Yixi would be responsible for the operation of the JV's nursing care facility.  Phoenix Creation Global would be responsible for providing or arranging the financial support for the construction and rental costs.

The parties intend to conduct due diligence over a 60-day period. In addition, they will work to enter into a definitive agreement for the JV within 30 days after that.

Shenyang Yixi operates 12 community elderly day-care centers (elderly day-care centers or activity centers) and a district home-care service center (a home-based elderly care center to provide service to the elderly at home) that are government-owned.

Union Bridge Holdings Limited (UGHL), closed Thursday's trading session at $1.03, up 9.57%, on 6,006 volume with 4 trades. The average volume for the last 3 months is 10,024 and the stock's 52-week low/high is $0.362/$4.25.

chart

InMed Pharmaceuticals, Inc. (IMLFF)

Promotion Stock Secrets and SmallCapVoice reported on InMed Pharmaceuticals, Inc. (IMLFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

InMed Pharmaceuticals, Inc. is a fully integrated, cannabinoid-based biopharmaceutical company. It takes advantage of its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs. The Company previously went by the name Cannabis Technologies, Inc. It changed its name to InMed Pharmaceuticals, Inc. in October of 2014. InMed has its corporate headquarters in Vancouver, British Columbia.

A preclinical stage biopharmaceutical business, InMed Pharmaceuticals specializes in the research and development (R&D) of novel, cannabinoid-based prescription drug therapies employing novel drug delivery systems. The Company conducts research, discovery, preclinical, regulatory, manufacturing and commercial development activities for its product candidates.

InMed Pharmaceuticals is presently developing pre-clinical product candidates. These comprise INM-750 for the treatment of Epidermolysis bullosa; INM-085 for the treatment of glaucoma; and INM-405 for the treatment of pain.

The Company’s lead product, INM-750 has numerous mechanisms-of-action in the skin to deliver symptomatic relief. These include accelerated wound healing, pain reduction, itch reduction, inflammation reduction, and also antimicrobial activity.

InMed’s INM-085 has a proprietary deliver system. INM-085 uses a one x per day hydrogel formulation. This is to address the major issues of non-compliance (dosing frequency, side effects and adherence). The Company’s INM-405 is centered on local administration for Peripheral Pain Management. INM-405 for Pain is targeting topical administration.

In March, InMed Pharmaceuticals announced the publication of a peer-reviewed article in Drug Delivery and Translational Research. The article, titled "A stimulus-responsive, in situ forming, nanoparticle-laden hydrogel for ocular drug delivery", presents results from a pre-clinical study co-sponsored by InMed. The article was co-authored by Dr. Sazzad Hossain, InMed Pharmaceuticals’ Chief Scientific Officer.

The Company originally announced completion of this study in October of last year. These proprietary data support what InMed believes to be a first-in-class nanoparticle-hydrogel formulation for cannabinoid delivery to the eye, resulting in enhanced drug uptake through the cornea and lens. The patent family for this discovery is now at the provisional stage. It will be converted to a PCT filing during this year.

InMed Pharmaceuticals is using its proprietary bioinformatics assessment tool to identify bioactive compounds in the cannabis plant, which have the potential to have physiological impacts on specific diseases. The objective is to identify new drug candidates that optimize therapeutic benefit while limiting adverse effects.

InMed Pharmaceuticals, Inc. (IMLFF), closed Thursday's trading session at $0.3801, up 4.17%, on 406,227 volume with 201 trades. The average volume for the last 3 months is 534,109 and the stock's 52-week low/high is $0.217/$1.46.

chart

Nano One Materials Corp. (NNOMF)

NetworkNewsWire, Charts and Trends, Penny Stock Tweets, Stockhouse, Insider Tracking, OTC Markets, Wallmine, GuruFocus, Dividend Investor, MarketWatch, Investors Hangout, Private Capital Newswire, Market Screener, Capital Cube, Wallet Investor, Canadian Insider, Barchart, 4-Traders, Morningstar, and Central Charts reported on Nano One Materials Corp. (NNOMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nano One Materials Corp. is developing patented technology for the low-cost production of high-performance battery materials used in electric vehicles, energy storage and consumer electronics. The Company’s mission is to establish its patented technology as a leading platform for the worldwide production of a new generation of nanostructured composite materials. Nano One Materials has its head office, laboratory, and pilot facility in Burnaby, British Columbia. The Company also has an office in Vancouver, British Columbia.

The processing technology addresses fundamental supply chain constraints through enabling broader raw materials specifications for use in lithium ion batteries. The process can be configured for a range of diverse nanostructured materials. In addition, it has the flexibility to shift with developing and future battery market trends and a varied range of other growth opportunities. Nano One Materials has 2 U.S. patents granted and numerous more pending in the U.S. and foreign jurisdictions.

The novel three-stage process uses equipment common to industry. The Company has constructed a pilot plant to demonstrate high volume production and to optimize its technology across a range of materials.

The core technology assembles low-cost raw materials in solution (including lithium, cobalt, magnesium) at high rates of production, before industrial driers and kilns complete the reaction. The three-stage process can produce many types of ceramic powders. It is already being engineered, with industrial partners NORAM and BC Research, for high volume production and fast commercialization.

At present, Nano One Materials has active contribution agreements with the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Sustainable Development Technology Canada, and the Automotive Supplier Innovation Program – all programs of the Government of Canada. Collectively, these funding sources are projected to extend the Company’s operating capital into Q1 2020.

In August, Mr. Dan Blondal, Nano One Materials’ Chief Executive Officer announced the launch of a project centered on improving the durability of lithium ion cathode materials with the support of the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). NRC IRAP will support the Company’s project to develop Coatings for High Durability Lithium ion Battery Cathodes. NRC IRAP will contribute up to $349,000 in non-dilutive and non-repayable funds between August 1, 2018 and May 31, 2020.

Mr. Blondal previously announced that its Lithium Iron Phosphate (LFP) cathode material, and the cost of making it, are outperforming international benchmarks and could be a disruptive force in the lithium ion battery market space. He said, “Major cathode producers have begun evaluating our LFP and initial results are consistent with the excellent battery performance we’ve been measuring in our lab. The preliminary economic modeling is also very compelling with LFP production costs conservatively estimated at 10 to 30 percent below industry standards.”

LFP is the cobalt-free, low cost, high durability, as well as safest cathode material of choice for lithium ion batteries. It is used in e-buses, e-bikes, power tools and grid storage systems for renewable energy. Presently, LFP is produced through either hydrothermal or solid-state methods.

Nano One Materials Corp. (NNOMF), closed Thursday's trading session at $0.94, up 0.67%, on 5,000 volume with 10 trades. The average volume for the last 3 months is 13,913 and the stock's 52-week low/high is $0.7174/$2.18.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Companies Explore Market Potential for Ready-to-Drink CBD Beverages,” featuring Youngevity International, Inc. (NASDAQ: YGYI). To hear the CannabisNewsAudio version, visit: http://cnw.fm/vNY60. To read the full editorial, visit: http://cnw.fm/TZr7d.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.56, up 0.61%, on 342,926 volume with 1,858 trades. The average volume for the last 3 months is 225,387 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN), a Canadian-based provider of services to help cannabis farmers and manufacturers establish and increase their brand awareness, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW"). TransCanna helps its clients in the cannabis industry get recognized by end consumers, who in turn purchase their products. The company offers, or will be offering, its services throughout most aspect of the ecosystem, from branding, design, transportation and distribution to marketing and sales.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $1.07, up 18.89%, on 131,110 volume with 39 trades. The stock's 52-week low/high is $0.77/$1.02.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Nicotine LLC, a wholly owned subsidiary of Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), has entered into a definitive agreement with Altria Group Inc. (NYSE: MO) to fund the research & development of Lexaria’s patented DehydraTECH™ technology. Also today, NetworkNewsWire released a report on the company detailing the development and out-licensing of LXRP’s disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. To view the full publication, titled “Definitive Agreement Marks Milestone for Alternative Nicotine Delivery Options,” visit: http://nnw.fm/xbD2Z.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.59, up 7.43%, on 694,314 volume with 675 trades. The average volume for the last 3 months is 188,319 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLSPF).

Popular demand inspired Plus Products Inc. (CSE: PLUS) (“PLUS™”) to create the fourth limited edition of its market-leading infused gummies- Pink Lemonade.  The gummies are available for a limited time at select dispensaries in California, and this year a portion of the proceeds from the launch will be donated to the National Parks Foundation. PLUS Pink Lemonade flavored gummies are a twist on a classic flavor that strikes the perfect balance between sweet and tangy.  They are precisely dosed with 3.5mg of THC and 1.5mg CBD. These Sativa gummies are sure to melt away the winter chill and leave you feeling delightfully refreshed.

Plus Products Inc. (CSE: PLUS) (OTC: PLSPF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLUS), closed the day's trading session at $3.75, up 5.90%, on 1,412 volume with 8 trades. The average volume for the last 3 months is 1,558 and the stock's 52-week low/high is $2.81/$4.25.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSXV: RIV) today announced that Narbe Alexandrian has been appointed as President of the Company, effective immediately. In this role, Narbe will lead the corporate development initiatives as well as manage the day-to-day business of the Company. He will report directly to Bruce Linton, Chief Executive Officer. Also today, the company provided an update on the operations of Canapar SrL (“Canapar), an Italian-based hemp production and processing platform and subsidiary of portfolio company, Canapar Corp.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.41, up 1.38%, on 476,641 volume with 681 trades. The average volume for the last 3 months is 448,619 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

At this year’s Consumer Electronics Show (Jan 8-11, 2019) in Las Vegas, the cybersecurity focus appeared to be on the Internet of Things (IoT). The proliferation of digital devices such as smart watches and home sensors connected to the internet has made the “threat landscape exponentially increase”, posing a headache for cybersecurity professionals (http://nnw.fm/JBo1p). Nevertheless, many consumers are unperturbed. A study conducted by McAfee, the computer security company, found that “58% of 2,000 consumers surveyed said they don't believe that they are responsible for ensuring their personal devices are secure.” Maybe an introduction to the innovative products from Cyberfort Software, Inc. (OTC: CYBF) that incorporate Content Filtering and Ad-Blocking may change minds.

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.23, up 15.00%, on 6,057 volume with 4 trades. The average volume for the last 3 months is 16,528 and the stock's 52-week low/high is $0.051/$69.00.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTCQB: SING), a client of CNW focused on acquiring companies that will benefit from the injection of growth capital and technology integration. To view the full publication, titled “New Laws Set Up US Cannabis Industry for Explosive Growth,” visit: http://cnw.fm/KtA55. Also today, the company announced that its subsidiary, SingleSeed, has added a new vertical to its robust line up in the launch of a new CBD product for dogs, available on SingleSeed.com. To view the full press release, visit: http://cnw.fm/TxH2a.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0199, up 3.11%, on 2,607,867 volume with 177 trades. The average volume for the last 3 months is 6,414,862 and the stock's 52-week low/high is $0.0106/$0.09.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTCMKTS: DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is excited to announce the broad nationwide expansion of its Where’s Weed segment, and its primary assets, the Where’s Weed Mobile App and WheresWeed.com, representing an online and mobile cannabis services hub that focuses on fast, secure, and efficient discovery, purchasing, and delivery scheduling of cannabis in both recreational and medical markets in the United States and Canada.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.02, up 0.25%, on 1,333,405 volume with 78 trades. The average volume for the last 3 months is 346,783 and the stock's 52-week low/high is $0.012/$0.14.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a report by CannabisNewsWire examining the case that state records that were published on January 14 show that Arizonans set a record in the state by consuming a total of 61 tons of different forms of medical marijuana. The report shows that Arizona medical cannabis dispensaries sold 2.5 tons of marijuana edibles last year. One interesting thing about this statistic is that in 2012, the entire state consumed that exact quantity of cannabis products. That year was the first full year since the medical marijuana was legalized.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.3256, off by 2.75%, on 123,070 volume with 303 trades. The average volume for the last 3 months is 185,260 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce the appointment of Dr. Rav Kumar, PhD as the Company's Chief Science Officer. Dr. Kumar will lead The Green Organic Dutchman's Science & Innovation Division and oversee all aspects of science-related initiatives including TGOD's science portfolio encompassing advanced and innovative global product lines for patients and consumers. Dr. Kumar will help drive innovation from concept to commercialization at the Company.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.20, off by 2.61%, on 439,341 volume with 672 trades. The average volume for the last 3 months is 1,000,959 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces its partnership with premium dietary supplements provider Forzagen to distribute ETST’s High Grade Full Spectrum Cannabinoids throughout Mexico and South America.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.70, off by 1.41%, on 12,783 volume with 18 trades. The average volume for the last 3 months is 42,593 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL)

The QualityStocks Daily Newsletter would like to spotlight United Battery Metals Corp. (UBMCF).

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) is a vanadium exploration company focused on becoming the first vanadium producer in North America. The company’s flagship project is the Wray Mesa Project, an exploration-stage vanadium property located in Montrose County, Colorado. The property consists of over 107 contiguous mining claims on about 3000 acres. United Battery Metals recently announced that it has tripled its vanadium rich land package in Colorado and Utah. The claims are located on land where both the surface and mineral ownership is held by the Bureau of Land Management (BLM) of the U.S. Department of Interior. Valid unpatented mining claims grant the holder the right of mineral possession as allowed by the General Mining Law of 1872, subject to the various state and federal rules and regulations pertaining to mineral exploitation.

Global demand for vanadium as a strategic metal has exploded in recent years. Vanadium price surges have hit recent highs of approximately $22.63 per pound from about $9 per pound last year.? As a result, mining companies are returning to exploration efforts for vanadium.

The Wray Mesa Project area is part of the La Sal Creek District, which has a long history of exploration and production efforts with records showing drill exploration likely started there in the late 1940s with geologists from the U.S. Geological Survey (USGS) and the Atomic Energy Commission, then continued from the 1960s through the 1980s with private sector interests involved. Based on historical records, the Wray Mesa Project appears to have very good to excellent potential with an inferred resource of 500,000 pounds of uranium- and a current estimated vanadium resource of 2,640,000 pounds as per the last 43-101 prepared in 2013 by Anthony Adkins who is a qualified geologist.

The world’s vanadium demand is set to increase significantly as China implements tighter controls over this critical element as it is used in infrastructure to strengthen steel. With trade war tensions mounting, the U.S. will likely be in dire need of a domestic supply of vanadium for use in steel plants opening nationwide and grid power storage. In fact, the White House has deemed vanadium one of 35 critical elements to United States national and economic security (USGS). US Steel announced additional plants opening nationwide, and this bull market in domestic steel production is likely to increase the demand for a domestic source of vanadium as China has begun restricting vanadium exports to the U.S. amid mounting tensions between the two countries over tariffs and certain critical elements such vanadium.

UBM utilized resource estimation software to model the mineralization detected in a number of the 715 historical and 24 recent drill holes within the project area. Results of the model run, minus the estimated effects of the historic mining, identify an indicated resource of approximately 85,500 short tons at an average grade of 0.16% eU308 for a total of 271,000 pounds of contained uranium. Inferred resources total 57,400 short tons at an average grade of 0.15% of eU308 for a total of about 169,000 pounds of contained uranium. The vanadium resource for the two categories, based on a conservative V:U ratio of 6:1, is 1,626,000 (O.95% average grade) and 1,014,000 (0.88% average grade) pounds, respectively.

Vanadium has multiple uses in modern society including being used in vanadium redox flow batteries (“VRFBs”), car charging stations, nuclear power plants and in steel manufacturing. An article in Mining.com notes that vanadium pentoxide (V2O5), which is used in the production of VRFBs used in energy storage systems, breached US$20 a pound in September 2018 for the first time since 2005, a four-fold increase from the start of 2017.

California recently announced that all homes and mid rises must install solar panels by 2020. Vanadium redox flow batteries (VRFBs) are by far the most superior batteries for large scale energy storage systems and the reason why the Vanadium Redox Flow batteries will dwarf the lithium battery demand. California was the first to announce this green initiative and many experts expect that the revolution will be implemented nationwide in the near future.

Vanadium is one of the 35 minerals deemed critical to the national security and economy of the United States. Among the important uses of vanadium are the following:

  • Fast-charging VRFBs have unique characteristics making them especially attractive when compared to conventional batteries. VRFBs can operate at any temperature, be charged and discharged at the same time, have greater design flexibility and a 25-plus year lifecycle. VRFB’s promise to be a major player in the green energy storage revolution because they are 100 percent reusable, recyclable, are nonflammable, compact, able to provide large grid energy storage, can be fully contained and are seen as a viable alternative to lithium-ion batteries.
  • VRFBs can be used in a variety of energy storage applications including microgrids, during peak shaving periods and for load leveling, as an uninterruptible power supply, for wind and solar farms, and as an off-grid power supply.
  • Approximately 85 percent of vanadium produced is used as ferrovanadium or as an additive to strengthen and harden steel used for applications in axles, crankshafts, gears, surgical instruments and tools, knives, jet engines, high-speed airframes, dental implants, and in seamless tubing for the aerospace, defense and bicycle industries.
  • Vanadium alloys are used in nuclear reactors because of the metal’s low neutron-absorbing properties.

The management team at United Battery Metals Corp. includes president, CEO and Director Matthew Rhoades, the former State Geologist for New Mexico and an accomplished professional geologist with direct working experience in exploration and development projects at numerous deposits and mines throughout the American West, Canada, Mexico and South America. He is joined by George Sharpe, a qualified Mineral Exploration Geoscientist, QP, MCIM and CGT, with over 23 years of global mineral exploration in iron coal, gold, base metals, rare earths, uranium, PGE’s, diamonds, iron and industrial minerals.

United Battery Metals Corp. (UBMCF), closed the day's trading session at $0.0653, up 6.18%, on 331,959 volume with 49 trades. The average volume for the last 3 months is 271,128 and the stock's 52-week low/high is $0.059/$1.58.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.3746, off by 3.52%, on 13,943 volume with 14 trades. The average volume for the last 3 months is 48,470 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0006, off by 25.00%, on 5,466,617 volume with 11 trades. The average volume for the last 3 months is 1,074,788 and the stock's 52-week low/high is $0.0006/$0.0085.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.